Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population

被引:102
作者
Tajouri, L
Ovcaric, M
Curtain, R
Johnson, MP
Griffiths, LR [1 ]
机构
[1] Griffith Univ, Sch Med Sci, Genom Res Ctr, Southport, Qld 4215, Australia
[2] Univ Queensland, Sch Med, Neuroimmunol Res Ctr, Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Dept Neurol, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
MS; VDR gene; RFLP association; linkage disequilibrium;
D O I
10.1080/01677060590949692
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Multiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) resulting in accumulating neurological disability. The disorder is more prevalent at higher latitudes. To investigate VDR gene variation using three intragenic restriction fragment length polymorphisms (Apa I, Taq I and Tok I) in an Australian MS case-control population. One hundred and four Australian MS patients were studied with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 104 age-, sex-, and ethnicity-matched controls were investigated as a comparative group. Our results show a significant difference of genotype distribution frequency between the case and control groups for the functional exon 9 VDR marker Taq I (P-Gen = 0.016) and interestingly, a stronger difference for the allelic frequency (p(AII) = 0.0072). The Apa I alleles were also found to be associated with MS (P-AII = 0.04) but genotype frequencies were not significantly different from controls (P-Gen = 0. 1). The Taq and Apa variants are in very strong and significant linkage disequilibrium (D' = 0.96, P < 0.0001). The genotypic associations are strongest for the progressive forms of MS (SP-MS and PP-MS). Our results support a role for the VDR gene increasing the risk of developing multiple sclerosis, particularly the progressive clinical subtypes of MS.
引用
收藏
页码:25 / 38
页数:14
相关论文
共 42 条
[1]  
ARNDT V, 2002, HEPATOLOGY, V35, P126
[2]   ApaI polymorphisms of the vitamin D receptor predict bone density of the lumbar spine and not racial difference in bone density in young men [J].
Bell, NH ;
Morrison, NA ;
Nguyen, TV ;
Eisman, J ;
Hollis, BW .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2001, 137 (02) :133-140
[3]   DIFFERENTIAL-EFFECTS OF 1,25-DIHYDROXYVITAMIN D3 ON HUMAN-LYMPHOCYTES AND MONOCYTE MACROPHAGES - INHIBITION OF INTERLEUKIN-2 AND AUGMENTATION OF INTERLEUKIN-1 PRODUCTION [J].
BHALLA, AK ;
AMENTO, EP ;
KRANE, SM .
CELLULAR IMMUNOLOGY, 1986, 98 (02) :311-322
[4]   1,25-dihydroxyvitamin D-3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis [J].
Cantorna, MT ;
Hayes, CE ;
DeLuca, HF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7861-7864
[5]  
Cantorna MT, 1998, J IMMUNOL, V160, P5314
[6]  
Cautain B, 2001, EUR J IMMUNOL, V31, P1132, DOI 10.1002/1521-4141(200104)31:4<1132::AID-IMMU1132>3.3.CO
[7]  
2-E
[8]   The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease [J].
Chabas, D ;
Baranzini, SE ;
Mitchell, D ;
Bernard, CCA ;
Rittling, SR ;
Denhardt, DT ;
Sobel, RA ;
Lock, C ;
Karpuj, M ;
Pedotti, R ;
Heller, R ;
Oksenberg, JR ;
Steinman, L .
SCIENCE, 2001, 294 (5547) :1731-1735
[9]   A genome-wide screen for linkage disequilibrium in Sardinian multiple sclerosis [J].
Coraddu, F ;
Lai, M ;
Mancosu, C ;
Cocco, E ;
Sawcer, S ;
Setakis, E ;
Compston, A ;
Marrosu, MG .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 143 (1-2) :120-123
[10]   Fracture history and bone loss in patients with MS [J].
Cosman, F ;
Nieves, J ;
Komar, L ;
Ferrer, G ;
Herbert, J ;
Formica, C ;
Shen, V ;
Lindsay, R .
NEUROLOGY, 1998, 51 (04) :1161-1165